Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Inghirami

Showing results (71-80 of 239) with videos related to

Pageof 24
Sort By:
Haematologica|January 10, 2013
The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemiaDavide Brusa, Sara Serra, Marta Coscia, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2019
Repurposing dasatinib for diffuse large B cell lymphomaClaudio Scuoppo, Jiguang Wang, Mirjana Persaud, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2009
Epidermal growth factor receptor gene in primary tumor and metastatic sites from non-small cell lung cancerLorenzo Daniele, Paola Cassoni, Elisa Bacillo, et al.
American Journal of Clinical Pathology|July 26, 2005
Follicular origin of a subset of CD5+ diffuse large B-cell lymphomasAndrea D Manazza, Lisa Bonello, Marco Pagano, et al.
Scientific Reports|August 6, 2020
Selective dysregulation of ROCK2 activity promotes aberrant transcriptional networks in ABC diffuse large B-cell lymphomaEdd Ricker, Akanksha Verma, Rossella Marullo, et al.
Human Gene Therapy|March 12, 2015
Cytokine-induced killer cells engineered with exogenous T-cell receptors directed against melanoma antigens: enhanced efficacy of effector cells endowed with a double mechanism of tumor recognitionAngela R Elia, Paola Circosta, Dario Sangiolo, et al.
Nature Communications|June 10, 2017
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicityClaire Vanpouille-Box, Amandine Alard, Molykutty J Aryankalayil, et al.
Frontiers in Immunology|January 31, 2022
Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and TreatmentAndré F Rendeiro, Charles Kyriakos Vorkas, Jan Krumsiek, et al.
Molecular Cell|December 25, 2024
3D chromatin hubs as regulatory units of identity and survival in human acute leukemiaGiovanni Gambi, Francesco Boccalatte, Javier Rodriguez Hernaez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Tim-3+ T-bet+ tumor-specific Th1 cells colocalize with and inhibit development and growth of murine neoplasmsWilliam J Simmons, Mythili Koneru, Mani Mohindru, et al.
Pageof 24

Showing results (71-80 of 239) with videos related to

Sort By:
Pageof 24
Haematologica|January 10, 2013
The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemiaDavide Brusa, Sara Serra, Marta Coscia, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2019
Repurposing dasatinib for diffuse large B cell lymphomaClaudio Scuoppo, Jiguang Wang, Mirjana Persaud, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2009
Epidermal growth factor receptor gene in primary tumor and metastatic sites from non-small cell lung cancerLorenzo Daniele, Paola Cassoni, Elisa Bacillo, et al.
American Journal of Clinical Pathology|July 26, 2005
Follicular origin of a subset of CD5+ diffuse large B-cell lymphomasAndrea D Manazza, Lisa Bonello, Marco Pagano, et al.
Scientific Reports|August 6, 2020
Selective dysregulation of ROCK2 activity promotes aberrant transcriptional networks in ABC diffuse large B-cell lymphomaEdd Ricker, Akanksha Verma, Rossella Marullo, et al.
Human Gene Therapy|March 12, 2015
Cytokine-induced killer cells engineered with exogenous T-cell receptors directed against melanoma antigens: enhanced efficacy of effector cells endowed with a double mechanism of tumor recognitionAngela R Elia, Paola Circosta, Dario Sangiolo, et al.
Nature Communications|June 10, 2017
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicityClaire Vanpouille-Box, Amandine Alard, Molykutty J Aryankalayil, et al.
Frontiers in Immunology|January 31, 2022
Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and TreatmentAndré F Rendeiro, Charles Kyriakos Vorkas, Jan Krumsiek, et al.
Molecular Cell|December 25, 2024
3D chromatin hubs as regulatory units of identity and survival in human acute leukemiaGiovanni Gambi, Francesco Boccalatte, Javier Rodriguez Hernaez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Tim-3+ T-bet+ tumor-specific Th1 cells colocalize with and inhibit development and growth of murine neoplasmsWilliam J Simmons, Mythili Koneru, Mani Mohindru, et al.
Pageof 24